Crinetics Pharmaceuticals (CRNX) Earnings Date, Estimates & Call Transcripts $31.24 +0.03 (+0.10%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$31.25 +0.01 (+0.03%) As of 05/16/2025 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Crinetics Pharmaceuticals Earnings Summary Crinetics Pharmaceuticals issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$1.04, which missed analysts' consensus estimates of -$0.99 by $0.05. Quarterly revenue fell 43.6% year-over-year to $0.36 million, above analyst estimates of $0.10 million. With a trailing EPS of -$3.82, Crinetics Pharmaceuticals' earnings are expected to decrease next year, from ($3.73) to ($4.11) per share. Latest Q1 Earnings DateMay. 8EstimatedConsensus EPS (May. 8) -$0.99 Actual EPS (May. 8) -$1.04 Missed By -$0.05 Actual Revenue (May. 8) $0.36MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Crinetics Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Crinetics Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCRNX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRNX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Crinetics Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.89-$0.88-$0.89Q2 20252-$0.99-$0.88-$0.94Q3 20252-$1.14-$0.95-$1.05Q4 20252-$1.22-$0.95-$1.09 Crinetics Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025-$0.99-$1.04 -$0.05-$1.04$0.10M$0.36M2/27/2025Q4 2024-$0.92-$0.88+$0.04-$0.88$0.73M-11/12/2024Q3 2024-$0.91-$0.96 -$0.05-$0.96$0.22M-8/8/2024Q2 2024-$0.86-$0.94 -$0.08-$0.94$0.47M$0.40M5/9/2024Q1 2024-$0.84-$0.93 -$0.09-$0.93$0.20M$0.64M2/28/2024Q4 2023-$0.89-$0.90 -$0.01-$0.90$0.20M-11/7/2023Q3 2023-$0.89-$1.01 -$0.12-$1.01-$0.35M8/8/2023Q2 2023-$0.85-$0.94 -$0.09-$0.94$5.00M$0.99M Crinetics Pharmaceuticals Earnings - Frequently Asked Questions When did Crinetics Pharmaceuticals announce their last quarterly earnings? Crinetics Pharmaceuticals (NASDAQ:CRNX) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on CRNX's earnings history. Did Crinetics Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Crinetics Pharmaceuticals (NASDAQ:CRNX) missed the analysts' consensus estimate of ($0.99) by $0.05 with a reported earnings per share (EPS) of ($1.04). Learn more on analysts' earnings estimate vs. CRNX's actual earnings. How can I listen to Crinetics Pharmaceuticals's earnings conference call? The conference call for Crinetics Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Crinetics Pharmaceuticals's conference call transcript? The conference call transcript for Crinetics Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Crinetics Pharmaceuticals generate each year? Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded annual revenue of $760,000.00. How much profit does Crinetics Pharmaceuticals generate each year? Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded net income of -$214.53 million. CRNX has generated -$3.82 earnings per share over the last four quarters. What is Crinetics Pharmaceuticals's EPS forecast for next year? Crinetics Pharmaceuticals's earnings are expected to decrease from ($3.73) per share to ($4.11) per share in the next year. More Earnings Resources from MarketBeat Related Companies Dr. Reddy's Laboratories Earnings Viatris Earnings Moderna Earnings Qiagen Earnings Ascendis Pharma A/S Earnings Roivant Sciences Earnings Revolution Medicines Earnings BridgeBio Pharma Earnings Blueprint Medicines Earnings Elanco Animal Health Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:CRNX) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRNX Stock Free CRNX Stock Alerts